A chemically modified antibody mediates complete eradication of tumours by selective disruption of tumour blood vessels

Organ transplantation and skin cancer: basic problems and new perspectives

(2010) Günther F.L. Hofbauer et al.   EXPERIMENTAL DERMATOLOGY

The development of the tumor vascular-disrupting agent ASA404 (vadimezan, DMXAA): current status and future opportunities

(2010) Michelle Head et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Self-Assembly Synthesis, Tumor Cell Targeting, and Photothermal Capabilities of Antibody-Coated Indocyanine Green Nanocapsules

(2010) Jie Yu et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Expression of the oncofetal ED-B-containing fibronectin isoform in hematologic tumors enables ED-B-targeted 131I-L19SIP radioimmunotherapy in Hodgkin lymphoma patients

(2009) S. Sauer et al.   BLOOD

Infarction of tumor vessels by NGR-peptide-directed targeting of tissue factor: experimental results and first-in-man experience

(2009) R. Bieker et al.   BLOOD

A review and update of the current status of the vasculature-disabling agent combretastatin-A4 phosphate (CA4P)

(2009) Dietmar W Siemann et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Three clinical-stage tumor targeting antibodies reveal differential expression of oncofetal fibronectin and tenascin-C isoforms in human lymphoma

(2009) Christoph Schliemann et al.   LEUKEMIA RESEARCH

Anticancer strategies involving the vasculature

(2009) Victoria L. Heath et al.   Nature Reviews Clinical Oncology

Complete eradication of human B-cell lymphoma xenografts using rituximab in combination with the immunocytokine L19-IL2

(2008) C. Schliemann et al.   BLOOD

Antiangiogenesis in haematological malignancies

(2008) William W. Li et al.   BRITISH JOURNAL OF HAEMATOLOGY

Temozolomide, thalidomide, and whole brain radiation therapy for patients with brain metastasis from metastatic melanoma

(2008) Michael B. Atkins et al.   CANCER

A high-affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo-vasculaturein vivo

(2008) Alessandra Villa et al.   INTERNATIONAL JOURNAL OF CANCER

A general method for the selection of high-level scFv and IgG antibody expression by stably transfected mammalian cells

(2008) K. Zuberbuhler et al.   PROTEIN ENGINEERING DESIGN & SELECTION